• Excellence

  • Tenacious

  • Relentless

Media Release

Dec 17, 2023

First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM

The study by YolTech is a single-arm, open-label, dose-escalation clinical trial

Share

e2_icon05.svg
e2_icon02.svg
e2_icon01.svg

LATESTNEWS